Amicus Therapeutics, Inc. (DELISTED) (FOLD:DL)
14.49
0.00 (0.00%)
USD |
NASDAQ |
May 07, 16:00
Amicus Therapeutics Max Drawdown (5Y) : 77.34% for April 30, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2026 | 77.34% |
| March 31, 2026 | 77.34% |
| February 28, 2026 | 77.34% |
| January 31, 2026 | 77.34% |
| December 31, 2025 | 77.34% |
| November 30, 2025 | 77.34% |
| October 31, 2025 | 77.34% |
| September 30, 2025 | 77.34% |
| August 31, 2025 | 77.34% |
| July 31, 2025 | 77.34% |
| June 30, 2025 | 77.34% |
| May 31, 2025 | 76.38% |
| April 30, 2025 | 74.97% |
| March 31, 2025 | 74.97% |
| February 28, 2025 | 74.97% |
| January 31, 2025 | 74.97% |
| December 31, 2024 | 74.97% |
| November 30, 2024 | 74.97% |
| October 31, 2024 | 74.97% |
| September 30, 2024 | 74.97% |
| August 31, 2024 | 74.97% |
| July 31, 2024 | 74.97% |
| June 30, 2024 | 74.97% |
| May 31, 2024 | 74.97% |
| April 30, 2024 | 74.97% |
| Date | Value |
|---|---|
| March 31, 2024 | 74.97% |
| February 29, 2024 | 74.97% |
| January 31, 2024 | 74.97% |
| December 31, 2023 | 74.97% |
| November 30, 2023 | 74.97% |
| October 31, 2023 | 74.97% |
| September 30, 2023 | 74.97% |
| August 31, 2023 | 74.97% |
| July 31, 2023 | 74.97% |
| June 30, 2023 | 74.97% |
| May 31, 2023 | 74.97% |
| April 30, 2023 | 74.97% |
| March 31, 2023 | 74.97% |
| February 28, 2023 | 74.97% |
| January 31, 2023 | 74.97% |
| December 31, 2022 | 74.97% |
| November 30, 2022 | 74.97% |
| October 31, 2022 | 74.97% |
| September 30, 2022 | 74.97% |
| August 31, 2022 | 74.97% |
| July 31, 2022 | 74.97% |
| June 30, 2022 | 74.97% |
| May 31, 2022 | 74.97% |
| April 30, 2022 | 71.55% |
| March 31, 2022 | 68.30% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| BioMarin Pharmaceutical, Inc. | 58.73% |
| Insmed, Inc. | 63.30% |
| Ligand Pharmaceuticals, Inc. | 72.85% |
| PTC Therapeutics, Inc. | 73.78% |
| Establishment Labs Holdings, Inc. | 75.42% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 0.2084 |
| Beta (5Y) | 0.4519 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 44.33% |
| Historical Sharpe Ratio (5Y) | 0.1033 |
| Historical Sortino (5Y) | 0.2083 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 17.29% |